Increased ICP management includes maintaining PaCO2 in which range to avoid cerebral ischemia?

Increased ICP management includes maintaining PaCO2 in which range to avoid cerebral ischemia?

• A. 20-25 mm Hg
• B. 40-45 mm Hg
• C. 50-55 mm Hg
• D. 30-35 mm Hg

Answer: (D)

Adequate ICP management relies on modulating cerebral blood flow through ventilation. CO2 directly affects cerebral vessels: lowering PaCO2 causes vasoconstriction and reduces cerebral blood volume and ICP, while raising PaCO2 causes vasodilation and increases ICP. To lower ICP without risking cerebral ischemia, target a PaCO2 around 30-35 mmHg. This mild hypocapnia helps decrease ICP but keeps cerebral blood flow adequate; lowering CO2 further (toward 20-25 mmHg) can lead to dangerous cerebral ischemia due to excessive vasoconstriction, and allowing PaCO2 to rise above normal (50-55 mmHg) would worsen ICP by vasodilation. Thus, 30-35 mmHg is the balance to reduce ICP while minimizing ischemic risk, typically as a temporary measure while treating the underlying cause.

Adequate ICP management relies on modulating cerebral blood flow through ventilation. CO2 directly affects cerebral vessels: lowering PaCO2 causes vasoconstriction and reduces cerebral blood volume and ICP, while raising PaCO2 causes vasodilation and increases ICP. To lower ICP without risking cerebral ischemia, target a PaCO2 around 30-35 mmHg. This mild hypocapnia helps decrease ICP but keeps cerebral blood flow adequate; lowering CO2 further (toward 20-25 mmHg) can lead to dangerous cerebral ischemia due to excessive vasoconstriction, and allowing PaCO2 to rise above normal (50-55 mmHg) would worsen ICP by vasodilation. Thus, 30-35 mmHg is the balance to reduce ICP while minimizing ischemic risk, typically as a temporary measure while treating the underlying cause.